Soe Paing, MD
Hospitalist · Jacksonville, FLNPI 1235364563
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Pfizer at 55.3% of the total. Reporting peaked in 2019 at $174 and has fallen 56.8% since, to $75 in 2025.
Across 31 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$327
- AbbVie$98
- E.r. Squibb & Sons, L.L.C.$51
- Novartis$51
- Portola Pharmaceuticals, LLC$20
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$17
- plus $28 from 2 others
What the payments were for
- Food & beverage$592100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $327 |
| AbbVie | 5 | $98 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Novartis | 3 | $51 |
| Portola Pharmaceuticals, LLC | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Medtronic | 1 | $14 |
| Merck | 1 | $14 |
How this compares
$592 in reported general payments places this provider in the 75th percentile of 1,570 hospitalist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vancomycin Hcl | 24 | $1,269 |
| Cefdinir | 23 | $268 |
| Pantoprazole Sodium | 28 | $126 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $85 |
| Atorvastatin Calcium | 15 | $60 |
| ClopidogrelClopidogrel Bisulfate | 13 | $56 |
| Metoprolol Succinate | 15 | $52 |
| Carvedilol | 14 | $49 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $47 |
| Furosemide | 11 | $46 |
| Amlodipine Besylate | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Jacksonville
- Carlos RojasJacksonville$6K
- Anil SuryaprasadJacksonville$4K
- Margaret WebbJacksonville$4K
- Jeffrey GarlandJacksonville$3K
- David ShupeJacksonville$3K
- Deepak ScindiaJacksonville$2K
- Murray EpsteinMiami$370K
- Oliver AbelaFort Myers$77K
- Joshua LenchusFort Lauderdale$73K
- Tuncay TaskesenThe Villages$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.